Your browser doesn't support javascript.
loading
Topical steroid withdrawal: a survey of UK dermatologists' attitudes.
Barlow, Richard; Proctor, Andrew; Moss, Celia.
Afiliação
  • Barlow R; Birmingham Children's Hospital, Birmingham, UK.
  • Proctor A; National Eczema Society, London, UK.
  • Moss C; Birmingham Children's Hospital, Birmingham, UK.
Clin Exp Dermatol ; 49(6): 607-611, 2024 May 21.
Article em En | MEDLINE | ID: mdl-38320214
ABSTRACT
The term topical steroid withdrawal (TSW) refers to a condition widely discussed on social media, but rarely mentioned in the medical literature. It typically involves a patient with chronic eczema who abruptly discontinues topical corticosteroids (TCS) believing they are ineffective and damaging. Symptoms include an acute eruption, worse than the previous eczema, of painful erythema followed by oozing, crusting, desquamation and sometimes prolonged systemic weakness. Patients self-diagnose and often avoid healthcare professionals who dismiss the diagnosis and persist in offering TCS, leaving them unsupported. We analysed 121 responses to a survey of UK dermatologists' attitudes to TSW. Views on aetiology included relapsed eczema, erythroderma and a social construct. A total of 88.4% (107/121) agreed that TSW needs better understanding and more research. Respondents earlier in their careers are more cautious than senior respondents about prescribing TCS long term because of TSW, suggesting a trend that might lead to better understanding, communication and management.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atitude do Pessoal de Saúde / Dermatologistas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atitude do Pessoal de Saúde / Dermatologistas Idioma: En Ano de publicação: 2024 Tipo de documento: Article